StockSelector.com
  Research, Select, & Monitor Sunday, August 25, 2019 9:10:04 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Cymabay Therapeutics, Inc.$5.53($.28)(4.82%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Cymabay Therapeutics, Inc. has an overall rank of 5322 out of 7130 stocks based on 4 positive rankings and 5 negative rankings.

Positive Rankings
Low Put/Call
Cymabay Therapeutics has a low Put/Call ratio of 0.06 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cymabay Therapeutics is ranked 146.
Debt-to-Equity
Cymabay Therapeutics rank is 188
Low vPut/Call
Cymabay Therapeutics has a low Put/Call ratio of 0.42 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cymabay Therapeutics is ranked 855.
Up EPS Surprise
Cymabay Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
90 Day Loss
Cymabay Therapeutics rank is 295
Negative ROA
Cymabay Therapeutics rank is 655
Negative ROE
Cymabay Therapeutics rank is 703
10 Day Loss
Cymabay Therapeutics rank is 1479
Price-to-Book
Cymabay Therapeutics rank is 2144







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.